Trial
NCT04249596
Tianeptine for Treatment Resistant Depression
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jonathan A. Javitch, MD, PhD
Collaborators
Icahn School of Medicine at Mount Sinai; Stanford University
Condition
Treatment Resistant Depression
Intervention
Tianeptine Sodium
Why stopped
Inadequate recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-23